Lanean...
CAR-Expressing Natural Killer Cells for Cancer Retargeting
Since the approval in 2017 and the outstanding success of Kymriah® and Yescarta®, the number of clinical trials investigating the safety and efficacy of chimeric antigen receptor-modified autologous T cells has been constantly rising. Currently, more than 200 clinical trials are listed on clinicaltr...
Gorde:
| Argitaratua izan da: | Transfus Med Hemother |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
S. Karger AG
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558329/ https://ncbi.nlm.nih.gov/pubmed/31244577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000495771 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Lanean...